THE Food and Drug Administration (FDA) has advised the Department of Health (DoH) to temporarily halt the use of the vaccine manufactured by British-Swedish drugmaker AstraZeneca to persons below 60 years old.
The recommendation comes after the European Medicines Agency (EMA) announced on Wednesday that it has found "possible links" between the AZD1222 vaccine and blood clots in 16 reported cases across Europe.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.